Top Ten most popular articles on Pharmafile.com this week
October 2, 2020Medical Communications
The top ten news stories this week focus on vaccines and treatments, with allegations Russia is sowing disinformation about COVID-19 …
Novartis unveils strong Phase 3 efficacy for one-time therapy Zolgensma in paediatric spinal muscular atrophy
October 1, 2020Research and Development Novartis, Zolgensma, spinal muscular atrophy
Novartis has lifted the curtain on new Phase 3 data from an ongoing trial of 33 participants on the efficacy …
Enlivex’s Allocetra improves COVID-19 recovery times, early data show
October 1, 2020Research and Development Allocetra, Enlivex
Israeli immunotherapy firm Enlivex Therapeutics has released tentatively positive data for its therapy Allocetra as a treatment for patients with …
Coronavirus transmission in India driven by superspreaders
October 1, 2020Research and Development
India’s largest contract tracing study has found that the virus has been transmitted through ‘super spreaders.’ The study was conducted …
Russia is spreading lies about COVID-19 vaccines, alleges UK Chief of Defence Staff
October 1, 2020Research and Development Hackers, Russia, Russians, coronavirus vaccine
Russia is sowing disinformation about COVID-19 vaccines to undermine inoculation efforts in Western aligned countries, according to a top UK …
High US drug prices driven by profits, House Oversight Committee report finds
October 1, 2020Research and Development
The rising cost of US drugs are primarily driven by the pursuit of profit by pharmaceutical companies, according to an …
NICE gives go-ahead for Sandoz’s Rizmoic to treat opioid-induced constipation
September 30, 2020Research and Development, Sales and Marketing NHS, NICE, Rizmoic, Sandoz, UK
The National Institute for Health and Care Excellence (NICE) has recommended Sandoz’s Rizmoic (naldemedine) for the treatment of opioid-induced constipation …
Company veteran Belén Garijo named as Merck KGaA’s first-ever female CEO
September 30, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck KGaA
German pharma firm Merck KGaA has taken the decision to appoint its first female Chief Executive Officer in its 352-year …
Judge allows $1.5 billion Tamiflu stockpiling lawsuit against Roche to go ahead
September 30, 2020Research and Development Roche, Tamiflu
A Maryland federal judge denied Roche’s motion to throw out a lawsuit that alleges the company defrauded the US and …
Brain-eating amoeba in Texas water supply kills six-year-old
September 30, 2020Research and Development amoeba, brain eating ameoba
Officials in Texas have said it could take two to three months to disinfect the water supply in Lake Jackson …
Pharmafile.com’s weekly COVID-19 news round-up
September 30, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, top ten
The coronavirus news this week focuses on the development of treatments to alleviate symptoms of the virus, as Australian biotech …
The October 2020 issue of Pharmafocus is available to read free online now!
September 29, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2020, October 2020, Pharmafocus, digital edition, pharma
The latest monthly edition of Pharmafocus is available to read for free online now! As the US sails past the …
Canadian approval for Reblozyl for transfusion-dependent anaemia in beta-thalassemia patients
September 29, 2020Manufacturing and Production, Sales and Marketing BMS, Canada, Reblozyl
Bristol Myers Squibb and Acceleron have managed to secure regulatory approval in Canada for Reblozyl (luspatercept) for the treatment of …
Pfizer’s Xeljanz approved by the FDA for the treatment of children with arthritis
September 29, 2020Manufacturing and Production
The FDA has approved Pfizer’s Xeljanz (tofacitinib) for the treatment of children and adolescents with active polyarticular course juvenile idiopathic …
Trump announces 150 million Abbott COVID-19 tests will be deployed across the US
September 29, 2020Manufacturing and Production
President Donald Trump announced on Monday that the government will distribute 150 million coronavirus tests from Abbott Laboratories across the …
FDA pauses the planning stages of Inovio’s late-stage COVID-19 vaccine trials
September 29, 2020Manufacturing and Production COVID-19 vaccine, FDA, coronavirus vaccines
The FDA has put Inovio’s planning stages for the final trials of its coronavirus vaccine on hold as the regulator …
Jyseleca secures European approval in rheumatoid arthritis
September 28, 2020Research and Development, Sales and Marketing Europe, Jyseleca, arthritis, pharma
The European Commission has awarded approval to Gilead and Galpagos for their oral JAK inhibitor Jyseleca (filgotinib) as a treatment …
Novel prophylactic nasal spray reduced COVID-19 replication by 96% in animal studies
September 28, 2020Research and Development, Sales and Marketing COVID-19, Ena Respiratory, Nasal Spray
Australian biotech Ena Respiratory has revealed new data demonstrating that its novel nasal spray almost halted replication of the SARS-CoV-2 …
FDA approves GlaxoSmithKline’s Nucala to treat hypereosinophilic syndrome
September 28, 2020Sales and Marketing
The FDA has announced its approval of GlaxoSmithKline’s Nucala (mepolizumab) as a treatment for hypereosinophilic syndrome (HES). This is specifically …
UK promises £500m to global vaccine sharing scheme
September 28, 2020Sales and Marketing
UK Prime Minister Boris Johnson has announced in a speech to the UN General Assembly that the UK is set …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
